By Deena Beasley(Reuters) -U.S. tariffs on pharmaceuticals could eventually mean higher prices for brand-name medicines, but in the near term the costs would likely be absorbed by drugmakers rather than patients whose payments are often set by health insurance.U.S. health insurers, which pay the bulk of prescription drug costs, act as a buffer between drugmakers and patients, with beneficiaries su ...
Investing.com -- Mizuho upgraded Cloudflare Inc (NYSE:NET) to “Outperform,” citing strengthening sales pipelines, rising adoption of its Workers AI product, and a favorable setup for growth reacceleration in the second half of 2025.“Our recent checks on NET were more favorable than we expected,” the analysts wrote, highlighting large-deal activity and growing momentum for AI inferen ...
(Reuters) -Abbott Laboratories maintained its annual profit forecast on Wednesday and announced $500 million in manufacturing and research investments in the U.S. in the face of tariff-induced uncertainty.The company, which makes nutritional products and medical devices such as glucose monitors, has operations in several international markets including China. It has 89 manufacturing facilities aro ...
Investing.com -- Shares of Veolia Environnement (EPA:VIE) traded lower after Jefferies downgraded the French utility to “underperform” from "hold" rating, citing earnings risk, strategy concerns and a lack of near-term catalysts, in a note dated Wednesday. The brokerage also cut its price target by 20% to €25, implying a 19% downside from the previous close.Jefferies analysts pointed to ...